ACRVVSBJDX• 3 Months (Normalized)
ACRV vs BJDX (Acrivon Therapeutics Inc. vs Bluejay Diagnostics Inc.)
Showing Closing Date Range from Jun, 18 to Sep, 16, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ACRV Performance $1.7
+8.28%
Acrivon Therapeutics Inc.
Normalized Baseline0.00%
BJDX Performance $0.81
-81.77%
Bluejay Diagnostics Inc.
Normalized Baseline0.00%
Alpha Spread Margin ACRV LEADS
+90.05%
ACRV outperforming by 90.05%
ACRVBJDX
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ACRV BJDX
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | ACRV Price | ACRV Gain (%) | BJDX Price | BJDX Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 16, 2026 | $1.70 | +8.28% | $0.81 | -81.77% | +90.05% |
| Sep 15, 2026 | $1.83 | +16.56% | $0.85 | -80.99% | +97.55% |
| Sep 14, 2026 | $1.96 | +24.84% | $0.85 | -80.94% | +105.78% |
| Sep 11, 2026 | $2.00 | +27.39% | $0.90 | -79.89% | +107.28% |
| Sep 10, 2026 | $2.04 | +29.94% | $1.01 | -77.35% | +107.29% |
| Sep 09, 2026 | $1.99 | +26.75% | $1.01 | -77.35% | +104.10% |
| Sep 08, 2026 | $2.10 | +33.76% | $1.03 | -76.91% | +110.67% |
| Sep 04, 2026 | $2.13 | +35.67% | $0.83 | -81.35% | +117.02% |
| Sep 03, 2026 | $2.06 | +31.21% | $0.85 | -80.96% | +112.17% |
| Sep 02, 2026 | $2.15 | +36.94% | $0.85 | -80.96% | +117.90% |
| Sep 01, 2026 | $2.07 | +31.85% | $0.85 | -80.99% | +112.84% |
| Aug 31, 2026 | $2.09 | +33.12% | $0.87 | -80.49% | +113.61% |
| Aug 28, 2026 | $2.06 | +31.21% | $0.90 | -79.82% | +111.03% |
| Aug 27, 2026 | $2.15 | +36.94% | $0.91 | -79.60% | +116.54% |
| Aug 26, 2026 | $2.08 | +32.48% | $0.89 | -79.98% | +112.46% |
Page 1 of 5